US Stock MarketDetailed Quotes
NRXS Neuraxis
- 3.150
- -0.120-3.67%
Close Nov 15 16:00 ET
21.99MMarket Cap-2622P/E (TTM)
3.410High3.120Low7.84KVolume3.340Open3.270Pre Close25.02KTurnover0.24%Turnover RatioLossP/E (Static)6.98MShares3.89052wk High-12.26P/B10.48MFloat Cap2.00052wk Low--Dividend TTM3.33MShs Float6.930Historical High--Div YieldTTM8.88%Amplitude1.800Historical Low3.193Avg Price1Lot Size
About Neuraxis Company
NeurAxis, Inc. develops neuromodulation therapies to address chronic and debilitating conditions in children. Its product IB-Stim is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.
Company Profile
SymbolNRXS
Company NameNeuraxis
Listing DateAug 9, 2023
Issue Price6.00
Founded2011
CEOMr. Brian Carrico
MarketAMEX
Employees19
Fiscal Year Ends12-31
Address11611 North Meridian Street,Suite 330
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-812-689-0791
Websitehttp://neuraxis.com
Company Executives
- Name
- Position
- Salary
- Brian Carrico
- President, Chief Executive Officer and Director
- 839.40K
- Timothy Henrichs
- Chief Financial Officer
- 43.70K
- Dr. Adrian Miranda
- Chief Medical Officer, Senior Vice President, Science and Technology
- 323.05K
- Dr. Thomas Carrico
- Chief Regulatory Officer, Compliance Officer and Privacy Officer
- 411.10K
- Kristin A. Ferge
- Independent Director
- --
- Beth Keyser
- Independent Director
- 43.70K
- Christopher Robin Brown
- Independent Director
- --
- Bradley Mitch Watkins
- Independent Director
- 43.70K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data